Skip to main content
. 2019 Aug 6;10(47):4907–4918. doi: 10.18632/oncotarget.27127

Figure 5. Cell proliferation assay of MCF7-C6 and RIBR cell lines with molecular-targeted and chemotherapeutic drugs.

Figure 5

(A) MCF-7 C6 cell lines treated with alpelisib (B) everolimus, and (C) U0126. (D) RIBR cell lines treated with alpelisib, (E) everolimus, and (F) U0126. (G) MCF-7 C6 cell lines treated with paclitaxel and (H) eribulin. (I), RIBR cell lines treated with paclitaxel and (J) eribulin. All experiments were treated with each drug for 3 days and measured relative to the negative control. The results are expressed as mean ± SD; * P < 0.05.